TY - JOUR
T1 - Characterization of the cell penetrating properties of a human salivary proline-rich peptide
AU - Radicioni, Giorgia
AU - Stringaro, Annarita
AU - Molinari, Agnese
AU - Nocca, Giuseppina
AU - Longhi, Renato
AU - Pirolli, Davide
AU - Scarano, Emanuele
AU - Iavarone, Federica
AU - Manconi, Barbara
AU - Cabras, Tiziana
AU - Messana, Irene
AU - Castagnola, Massimo
AU - Vitali, Alberto
PY - 2015
Y1 - 2015
N2 - Saliva contains hundreds of small proline-rich peptides most of which derive from the post-translational and post-secretory processing of the acidic and basic salivary proline-rich proteins.
Among these peptides we found that a 20 residue proline-rich peptide (p1932), commonly present in human saliva and patented for its antiviral activity, was internalized within cells of the oral mucosa. The cell-penetrating properties of p1932 have been studied in a primary gingival fibroblast cell line and in a squamous cancer cell line, and compared to its retro-inverso form. We observed by mass-spectrometry, flow cytometry and confocal microscopy that both peptides were internalized in the two cell lines on a time scale of minutes, being the natural form more efficient than the retro-inverso one. The cytosolic localization was dependent on the cell type: both peptide forms were able to localize within nuclei of tumoral cells, but not in the nuclei of gingival fibroblasts. The uptake was shown to be dependent on the culture conditions used: peptide internalization was indeed effective in a complete medium than in a serum-free one allowing the hypothesis that the internalization could be dependent on the cell cycle. Both peptides were internalized likely by a lipid raft-mediated endocytosis mechanism as suggested by the reduced uptake in the presence of methyl-ß-cyclodextrin. These results suggest that the natural peptide may play a role within the cells of the oral mucosa after its secretion and subsequent internalization. Furthermore, lack of cytotoxicity of both peptide forms highlights their possible application as novel drug delivery agents.
AB - Saliva contains hundreds of small proline-rich peptides most of which derive from the post-translational and post-secretory processing of the acidic and basic salivary proline-rich proteins.
Among these peptides we found that a 20 residue proline-rich peptide (p1932), commonly present in human saliva and patented for its antiviral activity, was internalized within cells of the oral mucosa. The cell-penetrating properties of p1932 have been studied in a primary gingival fibroblast cell line and in a squamous cancer cell line, and compared to its retro-inverso form. We observed by mass-spectrometry, flow cytometry and confocal microscopy that both peptides were internalized in the two cell lines on a time scale of minutes, being the natural form more efficient than the retro-inverso one. The cytosolic localization was dependent on the cell type: both peptide forms were able to localize within nuclei of tumoral cells, but not in the nuclei of gingival fibroblasts. The uptake was shown to be dependent on the culture conditions used: peptide internalization was indeed effective in a complete medium than in a serum-free one allowing the hypothesis that the internalization could be dependent on the cell cycle. Both peptides were internalized likely by a lipid raft-mediated endocytosis mechanism as suggested by the reduced uptake in the presence of methyl-ß-cyclodextrin. These results suggest that the natural peptide may play a role within the cells of the oral mucosa after its secretion and subsequent internalization. Furthermore, lack of cytotoxicity of both peptide forms highlights their possible application as novel drug delivery agents.
KW - Cell internalization
KW - Flow cytometry
KW - Laser scanning confocal microscopy
KW - Proline-rich peptide
KW - Cell internalization
KW - Flow cytometry
KW - Laser scanning confocal microscopy
KW - Proline-rich peptide
UR - http://hdl.handle.net/10807/70601
U2 - 10.1016/j.bbamem.2015.08.019
DO - 10.1016/j.bbamem.2015.08.019
M3 - Article
SN - 0006-3002
VL - 1848
SP - 2868
EP - 2877
JO - BIOCHIMICA ET BIOPHYSICA ACTA
JF - BIOCHIMICA ET BIOPHYSICA ACTA
ER -